Wed Feb 03 2021

Policlínica Nuestra Señora del Rosario is the newest addition to our list of already established customers in Spain.

The customer is a private hospital located in Ibiza. The hospital has around 70 beds offering both acute care treatment and out-patient treatments for locals and tourists. The uptake population is approximately 50,000 people and the hospital also has three smaller associated clinics.

The hospital will immediately implement suPARnostic® TurbiLatex on its Roche cobas 501 system. This decision is based on references from other hospital users in Spain and abroad without previous on-site experience.

Our product will be implemented to improve the hospital’s triage of COVID-19 patients as well as other patients in acute care.

Jakob Knudsen, Chief Executive Officer of ViroGates, said:

”We are happy to add another clinical customer to our list of already established customers in Spain. We are particularly encouraged to see that this customer has decided to implement suPARnostic® based on data from peers in Spain and abroad without previous on-site experience. This shows that clinical evidence, local reference hospitals and our targeted marketing work in combination to convince customers who have not been acquainted with our products previously.”

+800

published suPAR studies in leading medical journals

The suPARnostic® brand consists of 3 products:

Photo of The suPARnostic® Quick Triage kit

Quick Triage

A Point of Care Solution

Photo of suPARnostic® TurbiLatex

TurbiLatex

For Automated Systems

Photo of suPARnostic® ELISA

ELISA Assay

Clinical and Research

New Webinar

Webinar

Catch COVID-19

-Improve your triage

Sign up to view webinar recording

View recording

suPARnostic® by ViroGates